-
VRDN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Viridian Therapeutics (VRDN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 200.32 mm | 200.32 mm | 200.32 mm | 200.32 mm | 200.32 mm | 200.32 mm |
Cash burn (monthly) | (no burn) | (no burn) | 27.83 mm | 23.59 mm | 22.57 mm | 16.42 mm |
Cash used (since last report) | n/a | n/a | 111.92 mm | 94.86 mm | 90.77 mm | 66.02 mm |
Cash remaining | n/a | n/a | 88.40 mm | 105.45 mm | 109.55 mm | 134.30 mm |
Runway (months of cash) | n/a | n/a | 3.2 | 4.5 | 4.9 | 8.2 |
13F holders | Current |
---|---|
Total holders | 173 |
Opened positions | 45 |
Closed positions | 17 |
Increased positions | 65 |
Reduced positions | 41 |
13F shares | Current |
---|---|
Total value | 1.96 tn |
Total shares | 96.67 mm |
Total puts | 438.70 k |
Total calls | 581.00 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
FMR | 11.18 mm | $254.42 bn |
BlackRock | 4.80 mm | $109.29 bn |
Vanguard | 4.42 mm | $100.56 bn |
VR Adviser | 3.88 mm | $88.33 bn |
Deep Track Capital | 3.75 mm | $85.33 bn |
Venrock Healthcare Capital Partners III | 3.58 mm | $79.27 mm |
Fairmount Funds Management | 3.45 mm | $78.39 bn |
Paradigm Biocapital Advisors | 2.90 mm | $65.88 bn |
Perceptive Advisors | 2.81 mm | $63.99 bn |
Commodore Capital | 2.55 mm | $58.02 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Sep 24 | Stephen F. Mahoney | Common Stock | Buy | Acquire P | No | No | 23.33 | 21,400 | 499.26 k | 21,400 |
27 Sep 24 | Beetham Thomas W. | Common Stock | Buy | Acquire P | No | No | 23.41 | 5,000 | 117.05 k | 6,000 |
13 Sep 24 | Fairmount Funds Management | Common Stock | Buy | Acquire P | Yes | No | 18.75 | 1,600,000 | 30.00 mm | 3,445,813 |
26 Jun 24 | Harwin Peter Evan | Stock Option Common Stock | Grant | Acquire A | Yes | No | 12.31 | 21,000 | 258.51 k | 21,000 |
26 Jun 24 | Morris Arlene | Stock Option Common Stock | Grant | Acquire A | No | No | 12.31 | 21,000 | 258.51 k | 21,000 |